.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Colorcon
US Department of Justice
Baxter
Daiichi Sankyo
Boehringer Ingelheim
Cantor Fitzgerald
Mallinckrodt
Cipla

Generated: December 14, 2017

DrugPatentWatch Database Preview

CARBATROL Drug Profile

« Back to Dashboard

When do Carbatrol patents expire, and when can generic versions of Carbatrol launch?

Carbatrol is a drug marketed by Shire and is included in one NDA.

The generic ingredient in CARBATROL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-003Sep 30, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-001Sep 30, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-002Sep 30, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CARBATROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-003Sep 30, 1997► Subscribe► Subscribe
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-002Sep 30, 1997► Subscribe► Subscribe
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-001Sep 30, 1997► Subscribe► Subscribe
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-002Sep 30, 1997► Subscribe► Subscribe
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-001Sep 30, 1997► Subscribe► Subscribe
ShireCARBATROLcarbamazepineCAPSULE, EXTENDED RELEASE;ORAL020712-003Sep 30, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for CARBATROL

Drugname Dosage Strength RLD Submissiondate
carbamazepineExtended-release Capsules100 mg and 200 mgCarbatrol2/2/2006

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Fuji
Healthtrust
Farmers Insurance
Cantor Fitzgerald
Baxter
Fish and Richardson
Colorcon
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot